Paroxysmal nocturnal haemoglobinuria
Not yet recruitingStudy of Pozelimab and Cemdisiran in Adults with Paroxysmal Nocturnal Hemoglobinuria Not Responding Well to Current C5 Inhibitor Treatment
Study of Pozelimab and Cemdisiran in Adults with Paroxysmal Nocturnal Hemoglobinuria Not Responding Well to Current C5 Inhibitor Treatment
- Disease:Paroxysmal nocturnal haemoglobinuria
- Substances:CemdisiranPozelimab
Poland- Participants:18–64 years · 65+ years
- Substances:Cemdisiran
- Sponsor:Regeneron Pharmaceuticals Inc.











